Asamli, Kaiser U.

HRN: 21-47-76  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2022
AZITHROMYCIN 500MG TABLET (TAB)
06/22/2022
06/26/2022
PO
500mg/tab
OD
CAP MR
Waiting Final Action 
06/22/2022
CEFTRIAXONE 1G (VIAL)
06/22/2022
06/29/2022
IV
2gms
OD
CAP MR
Waiting Final Action 
06/30/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/30/2022
07/06/2022
IV
1.5gms
Q6hrs
Empiric
Waiting Final Action 
07/25/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/25/2022
07/31/2022
IV
4.5g
Q6h
Pleural Abscess, Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: